As part of Omnicare Inc. OCR Week, “today we discus reimbursement and how it impacts the company,” J.P. Morgan reports.
“While Omnicare primarily serves nursing homes, as patients are covered under several different types of payors, the company is exposed to potential reimbursement pressure from multiple areas, which we discuss in greater detail,” J.P. Morgan writes.
“That said, we note that the company does assume some impact for further reimbursement pressure in its guidance. As a reminder, we will host a conference call today with John Figueroa, CEO of Omnicare, where we will discuss current industry dynamics and the company's strategy.”
Omnicare closed Tuesday at $31.44.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in